Evidence map›Paper›PMID 27539374›Full record

ArticleThe Journal of neuropsychiatry and clinical neurosciences2017

The Prevalence of Bipolar Disorders and Association With Quality of Life in a Cohort of Patients With Multiple Sclerosis.

Adalia H Jun-O'Connell, Ankur Butala, Idanis Berrios Morales, Nils Henninger, Kristina M Deligiannidis, Nancy Byatt, Carolina Ionete

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of neuropsychiatry and clinical neurosciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Medical Comorbidities in Bipolar Disorder.Current psychiatry reports · 2018
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Adalia H Jun-O'ConnellFrom the Department of Neurology, University of Massachusetts Medical School, Worcester, Mass (AJ-O, IBM, NH); the Department of Neurology, Johns Hopkins Medical School, Baltimore (AB); the Department of Psychiatry, Center for Psychopharmacologic Research and Treatment, University of Massachusetts Medical School, Worcester, Mass (KMD); the Department of Psychiatry, University of Massachusetts Medical School, Worcester, Mass (NB);and the Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, Mass. (CI).
Ankur ButalaFrom the Department of Neurology, University of Massachusetts Medical School, Worcester, Mass (AJ-O, IBM, NH); the Department of Neurology, Johns Hopkins Medical School, Baltimore (AB); the Department of Psychiatry, Center for Psychopharmacologic Research and Treatment, University of Massachusetts Medical School, Worcester, Mass (KMD); the Department of Psychiatry, University of Massachusetts Medical School, Worcester, Mass (NB);and the Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, Mass. (CI).
Idanis Berrios MoralesFrom the Department of Neurology, University of Massachusetts Medical School, Worcester, Mass (AJ-O, IBM, NH); the Department of Neurology, Johns Hopkins Medical School, Baltimore (AB); the Department of Psychiatry, Center for Psychopharmacologic Research and Treatment, University of Massachusetts Medical School, Worcester, Mass (KMD); the Department of Psychiatry, University of Massachusetts Medical School, Worcester, Mass (NB);and the Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, Mass. (CI).
Nils HenningerFrom the Department of Neurology, University of Massachusetts Medical School, Worcester, Mass (AJ-O, IBM, NH); the Department of Neurology, Johns Hopkins Medical School, Baltimore (AB); the Department of Psychiatry, Center for Psychopharmacologic Research and Treatment, University of Massachusetts Medical School, Worcester, Mass (KMD); the Department of Psychiatry, University of Massachusetts Medical School, Worcester, Mass (NB);and the Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, Mass. (CI).
Kristina M DeligiannidisFrom the Department of Neurology, University of Massachusetts Medical School, Worcester, Mass (AJ-O, IBM, NH); the Department of Neurology, Johns Hopkins Medical School, Baltimore (AB); the Department of Psychiatry, Center for Psychopharmacologic Research and Treatment, University of Massachusetts Medical School, Worcester, Mass (KMD); the Department of Psychiatry, University of Massachusetts Medical School, Worcester, Mass (NB);and the Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, Mass. (CI).
Nancy ByattFrom the Department of Neurology, University of Massachusetts Medical School, Worcester, Mass (AJ-O, IBM, NH); the Department of Neurology, Johns Hopkins Medical School, Baltimore (AB); the Department of Psychiatry, Center for Psychopharmacologic Research and Treatment, University of Massachusetts Medical School, Worcester, Mass (KMD); the Department of Psychiatry, University of Massachusetts Medical School, Worcester, Mass (NB);and the Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, Mass. (CI).
Carolina IoneteFrom the Department of Neurology, University of Massachusetts Medical School, Worcester, Mass (AJ-O, IBM, NH); the Department of Neurology, Johns Hopkins Medical School, Baltimore (AB); the Department of Psychiatry, Center for Psychopharmacologic Research and Treatment, University of Massachusetts Medical School, Worcester, Mass (KMD); the Department of Psychiatry, University of Massachusetts Medical School, Worcester, Mass (NB);and the Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, Mass. (CI).
Johns Hopkins University · US

Funding

Neuroendocrine and Neuroimaging Endophenotypes in Postpartum DepressionK23MH097794 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DELIGIANNIDIS, KRISTINA MARIE · 2013 to 2017
$897k
NIMH NIH HHS K23 MH097794NIMH NIH HHS L30 MH104713
6 · The paper itself

Abstract

Clinical observations of mood instability in multiple sclerosis (MS) have led to the hypothesis that bipolar disorder (BD) may be more prevalent in persons with MS than in the general population. This cross-sectional study assesses the prevalence of BD among patients with MS using standardized psychiatric diagnostic interviews and evaluates quality of life. This study demonstrates a higher prevalence of BD in patients with MS compared with the general population. It also reveals the negative impact of BD on quality of life, raises the concern that BD can occur before the onset of neurological symptoms in MS, and suggests that, in some cases, BD may delay diagnosis of MS.

Indexed as

Quality of LifeAdultBipolar DisorderCohort StudiesComorbidityCross-Sectional StudiesFemaleHumansInterview, PsychologicalMaleMiddle AgedMultiple SclerosisPrevalenceSelf ReportTertiary Care Centers

Identifiers

PMID27539374
PMCPMC5288280
OpenAlexW2510400139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.